Elsevier Ltd

SHERPA: Unknown

People

  1. Tallman
    Tallman
  2. Abdel-Wahab
    Abdel-Wahab
  3. Jhanwar
    Jhanwar
  4. Devlin
    Devlin
  5. Stein
    Stein
  6. Levine
    Levine
  7. Berman
    Berman
  8. Clarkson
    Clarkson
  9. Derkach
    Derkach
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (82)
  2. Hematologic Malignancies, Division of (77)
  3. Center for Hematologic Malignancies (72)
  4. Adult Leukemia (52)
  5. GSK Faculty (33)
  6. Epidemiology and Biostatistics (26)
  7. Tow Center for Developmental Oncology (TCDO) (23)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (20)
  9. Biostatistics Service (18)
  10. Executive Committee, Center for Hematologic Malignancies (18)
Search Within
Formats
  1. Journal Article (109)
  2. Meeting Abstract (26)
  3. Review (2)
  4. Research Letter (1)
Groups
  1. Department of Medicine (82)
  2. Hematologic Malignancies, Division of (77)
  3. Center for Hematologic Malignancies (72)
  4. Adult Leukemia (52)
  5. GSK Faculty (33)
  6. Epidemiology and Biostatistics (26)

More Groups

People
  1. Martin Tallman (27)
  2. Virginia Klimek (10)
  3. Omar Abdel-Wahab (9)
  4. Suresh Jhanwar (9)
  5. Eytan Stein (8)
  6. Sean Devlin (8)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (12)
  4. 2022 (8)
  5. 2021 (4)
  6. 2020 (4)

More Years

Publications
  1. Leukemia Research (120)
  2. Best Practice & Research: Clinical Gastroenterology (5)
  3. Heliyon (3)
  4. Marine Environmental Research (3)
  5. Behaviour Research and Therapy (2)
  6. International Journal of Immunopharmacology (2)

More Publications

Results (138)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rare genetic determinants of clonal hematopoiesis and progression to hematologic malignancies
    Meeting Abstract

    Liu, J.; Wiley, B.; Chan, I.; Batchi-Bouyou, A.; Zong, X.; Ding, L.; Cao, Y.; Offit, K.; Stadler, Z.; Link, D.; more...
    Leukemia Research (2023)

    Fulltext@MSK | Save
  • Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia
    Journal Article

    Atchley, E.; Weis, T. M.; Derkach, A.; Galera, P. K.; Xiao, W.; Glass, J.; DeWolf, S.; Roshal, M.; Shah, R.; Stump, S. E.
    Leukemia Research (2023)

    Fulltext@MSK | Save
  • Nebulization of pharmacological solutions with an innovative medical device based on microvaporization
    Journal Article

    Brandimarte, B.; Di Rienzo Businco, L.; Cappello, F.; Fiore, R.; Bastone, G.; Gualdi, G.; Sollaku, S.; Casciani, E.; Tortorella, F.; Longo, P.; more...
    Heliyon (2023)

    Fulltext@MSK | Save
  • Prostate cancer extracellular vesicle digital scoring assay – A rapid noninvasive approach for quantification of disease-relevant mRNAs
    Journal Article

    Wang, J. J.; Sun, N.; Lee, Y. T.; Kim, M.; Vagner, T.; Rohena-Rivera, K.; Wang, Z.; Chen, Z.; Zhang, R. Y.; Lee, J.; more...
    Nano Today (2023)

    Fulltext@MSK | Save
  • A phase I trial of targeted immunotherapy with daratumumab following myeloablative total body irradiation (TBI)-based conditioning and allogeneic hematopoietic cell transplantaton in children, adolescents and young adults with high-risk T-cell acute lymphoblastic leukemia and lymphoma (T- ALL/T-LLy) (ALLO-T-DART) (IND 159396): A PTCTC facilitated study
    Meeting Abstract

    Quigg, T.; Flower, A.; Teachey, D.; Lim, M.; Chu, Y.; Harrison, L.; Morris, E.; Gardenswartz, A.; Hochberg, J.; Ozkaynak, M.; more...
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Burkitt lymphoma and high-grade B-cell lymphphoma with 11q abberrations share a transcriptional profile resembling a subpopulation of early dark zone cells
    Meeting Abstract

    Di Stefano, G.; Chteinberg, E.; Loeffler-Wirth, H.; Hillebrecht, S.; Wagener, R.; Abramov, D.; Burkhardt, B.; Louissant, A.; Horn, H.; Mottok, A.; more...
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Real-world analysis of the safety/tolerability of gilteritinib in combination with mold-active azole prophylaxis
    Research Letter

    King, A. C.; Derkach, A.; Weis, T. M.; Stump, S. E.; Ciervo, J. R.; Ranaghan, C. P.; Stein, E. S.
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Dermatologic adverse events associated with IDH inhibitors ivosidenib and enasidenib for the treatment of acute myeloid leukemia
    Journal Article

    Parisi, R.; Cowen, E. A.; Stoll, J. R.; Zhu, H.; Dusza, S.; Pulitzer, M. P.; Stein, E. M.; Markova, A.
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling
    Journal Article

    Ganzel, C.; Sun, Z.; Baslan, T.; Zhang, Y.; Gönen, M.; Abdel-Wahab, O. I.; Racevskis, J.; Garrett-Bakelman, F.; Lowe, S. W.; Fernandez, H. F.; more...
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax
    Journal Article

    Bewersdorf, J. P.; Shallis, R. M.; Derkach, A.; Goldberg, A. D.; Stein, A.; Stein, E. M.; Marcucci, G.; Zeidan, A. M.; Shimony, S.; DeAngelo, D. J.; more...
    Leukemia Research (2022)

    Fulltext@MSK | Save

    • Elsevier Ltd – authorized name for: